BMRA Q1 2026 Earnings Loss of 044 Per Share Amid No Revenue Disclosure ARVN Q1 2026 Earnings BetterThanExpected Loss Amid No Revenue REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs KW Q1 2026 Earnings EPS Surprise of 1647 Highlights Cost Discipline Amidst Flat Revenue LMB Q1 2026 Earnings Staggering EPS Surprise of Over 1000 Masks a 224 Stock Decline Phoenix Education Partners Inc PXED Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response